Results 101 to 110 of about 30,081 (162)

Plasma exosomal fibroblast activation protein: a novel biomarker links fatty acid metabolic dysregulation to systemic lupus erythematosus. [PDF]

Arthritis Res Ther
Zhang J, Chen M, Yang C, Zang J, Sun W, Wang H, Zhang M, Sun J, Li H, Xu D.   +9 more
europepmc   +1 more source

Pouch cancer in familial adenomatous polyposis. Incidence, risk factors and literature review: a propos of three rare cases. [PDF]

Arq Bras Cir Dig
Campos FG, Martinez CAR, Moura RN, Safatle-Ribeiro AV, Marques CFS, Ribeiro Junior U, Herman P.   +6 more
europepmc   +1 more source

Letter to the editor: TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells. [PDF]

J Transl Med
Han Y, Zheng Z, Li X, Fan W.
europepmc   +1 more source

High-Performance Water Purification and Synergistic Hydrovoltaic by Avocado Peels Decorated With Carbon Dots. [PDF]

Small Sci
Yang X, Chi Y, Shi W.
europepmc   +1 more source

FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery. [PDF]

EJNMMI Res
Holst T, Dierks A, Patt M, Wienand G, Müller L, Pfob CH, Kircher M, Stock S, Lapa C, Girdauskas E, Bundschuh RA.   +10 more
europepmc   +1 more source

Fibroblast activation protein inhibitor (FAPI) PET imaging in pulmonary fibrosis: pathophysiology, clinical utility, and emerging theranostic applications. [PDF]

Respir Res
Al-Waqeerah A, He H, Bashah A, Ghaleb E, Wang N, Gao L.   +5 more
europepmc   +1 more source

Erasable FAP Targeted Spray-On Probe for Fluorescence-Guided Surgery. [PDF]

Adv Sci (Weinh)
Rabinowitz Z, Deutsch-Williams RJ, Weissleder R.   +2 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Genotype – phenotype correlation in FAP

Amyloid: the International Journal of Experimental and Clinical Investigation: the Official Journal of the International Society of Amyloidosis, 2012
Familial Amyloidotic Polyneuropathy (FAP) was initially classified into different types based on the clinical presentation. FAP Type I included patients with predominant upper limb neuropathy, while Type II patients had initial lower limb involvement. Further confusing the issue was the description of FAP Types III and IV, which proved to result from ...
exaly   +3 more sources

Establishment of FAP-overexpressing Cells for FAP-targeted Theranostics

Current Medical Science, 2023
Fibroblast activation protein (FAP) has been widely studied and exploited for its clinical applications. One of the difficulties in interpreting reports of FAP-targeted theranostics is due to the lack of accurate controls, making the results less specific and less confirmative.
Hui-Ru, Jian, Wen-Hao, Niu, Zhuo-Shuo, Xu, Jia-Xu, Zhu, Xin, Pan, Yi-Rui, Zhang, Ping, Lei, Fa-Qing, Huang, Yong, He   +8 more
openaire   +2 more sources

Update on Surgical Management of FAP

Clinics in Colon and Rectal Surgery, 2023
AbstractFamilial adenomatous polyposis (FAP) is an autosomal dominant disease caused by pathogenic germline adenomatous polyposis coli mutation, and characterized with multiple adenomas in the colon and the rectum. Various genetic variants have been confirmed to be associated with corresponding FAP phenotypes, which play important roles in the ...
Tianqi, Zhang, Ye, Xu
openaire   +2 more sources